Please assess the completion status of the following clinical trial:

Trial Title: The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient's weight has been stable for at least 6 weeks~* Patient is in good health based on medical history, physical exam, and laboratory tests~* Patient has dyslipidemia~Exclusion Criteria :~* Patient has a history of stroke, seizures, or major neurological disorders~* Patient has a history of cancer~* Patient is currently taking any lipid-lowering medications or substances except for statins~* Patient consumes excessive amounts of alcohol or caffeine~* Patient has multiple and/or severe allergies to food or drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Panel A (Type: EXPERIMENTAL): Period 1: atorvastatin + placebo to MK0859; Period 2: atorvastatin + MK0859
- Panel B (Type: EXPERIMENTAL): Period 1: placebo to atorvastatin + placebo to MK0859; Period 2: MK0859 + placebo to atorvastatin

Based on this trial design, predict the completion outcome and termination type (if applicable).